JUNS vs. KURA, OMER, EBS, ERAS, VERV, SVRA, STOK, RNAC, ALT, and ANAB
Should you be buying Jupiter Neurosciences stock or one of its competitors? The main competitors of Jupiter Neurosciences include Kura Oncology (KURA), Omeros (OMER), Emergent BioSolutions (EBS), Erasca (ERAS), Verve Therapeutics (VERV), Savara (SVRA), Stoke Therapeutics (STOK), Cartesian Therapeutics (RNAC), Altimmune (ALT), and AnaptysBio (ANAB). These companies are all part of the "pharmaceutical preparations" industry.
Jupiter Neurosciences vs.
Jupiter Neurosciences (NASDAQ:JUNS) and Kura Oncology (NASDAQ:KURA) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their community ranking, analyst recommendations, profitability, risk, institutional ownership, dividends, media sentiment, valuation and earnings.
Kura Oncology received 424 more outperform votes than Jupiter Neurosciences when rated by MarketBeat users. However, 100.00% of users gave Jupiter Neurosciences an outperform vote while only 69.44% of users gave Kura Oncology an outperform vote.
In the previous week, Kura Oncology had 3 more articles in the media than Jupiter Neurosciences. MarketBeat recorded 3 mentions for Kura Oncology and 0 mentions for Jupiter Neurosciences. Kura Oncology's average media sentiment score of 1.00 beat Jupiter Neurosciences' score of 0.94 indicating that Kura Oncology is being referred to more favorably in the news media.
Kura Oncology has a consensus target price of $27.38, indicating a potential upside of 270.43%. Given Kura Oncology's higher possible upside, analysts clearly believe Kura Oncology is more favorable than Jupiter Neurosciences.
Jupiter Neurosciences' return on equity of 0.00% beat Kura Oncology's return on equity.
Summary
Kura Oncology beats Jupiter Neurosciences on 5 of the 9 factors compared between the two stocks.
Get Jupiter Neurosciences News Delivered to You Automatically
Sign up to receive the latest news and ratings for JUNS and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Jupiter Neurosciences Competitors List
Related Companies and Tools
This page (NASDAQ:JUNS) was last updated on 1/22/2025 by MarketBeat.com Staff
Free JUNS Stock Alerts